Yuan Jin

Dr. Yuan Jin

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 November 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
YJYuan Jin
Yuan Jin
XLXiaozhou Liu
Xiaozhou Liu
QZQiong Zhang
Qiong Zhang
YXYing Xiong
Ying Xiong
YHYao Hu
Yao Hu
Yu SunYu Sun
Yu Sun
Background: Hearing loss (HL) is the most common disorder in newborns with a highly heterogeneous genetic background. Despite significant progress in screening and identifying genes related to congenital hearing loss, there are still candidate genes implicated in HL that remain undiscovered. Methods: We investigated HL in 43 Chinese families by segregating bilateral sensorineural HL via whole-exome sequencing (WES) and Sanger sequencing. Results: Variants were found in 10 known non-syndromic hearing loss (NSHL) genes, 5 known syndromic hearing loss (SHL) genes, and 1 candidate HL gene, ATP7B. RNA sequencing revealed ATP7B mRNA expression in developing and adult cochleae. The immunohistochemistry of the adult mouse cochlear tissue revealed the prominent expression of ATP7B in the organ of Corti and the spiral ganglion neuron. Overall, we propose a new candidate gene, ATP7B, for congenital hearing loss and novel variants in known HL genes, which expands our understanding of the etiology of HL. Conclusions: The next-generation sequencing could effectively improve the etiological diagnosis rate of congenital hearing loss in children.

Verified
Journal Article
Open access
PDF file
YJYuan Jin
Yuan Jin
SLShang Li
Shang Li
QZQiong Zhang
Qiong Zhang
BGBei Guo
Bei Guo
YXYing Xiong
Ying Xiong
WCWei Chen
Wei Chen
Hearing loss (HL) is the most common sensory disorder, affecting over 430 million individuals, and its prevalence continues to rise steadily. Thyroid hormone (TH) signaling is a key endocrine regulator that critically governs key processes in cochlear development, such as sensory hair cell differentiation, ion channel expression, and synaptic maturation. TH deficiency can lead to different types of hearing loss, with or without cochlear structural deformity. Moreover, TH deficiency in pregnant women can cause hearing impairment in newborns. This review synthesizes the mechanisms by which TH signaling contributes to cochlear development and pathogenesis of hearing loss. By integrating insights from human studies and animal models, we discuss the prognostic significance and clinical applicability of TH signaling levels, highlighting the indispensable role of TH signaling in advancing personalized strategies for the diagnosis and management of HL.

30 October 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
Yu SunYu Sun
Yu Sun
WCWei Chen
Wei Chen
YJYuan Jin
Yuan Jin
XLXiaozhou Liu
Xiaozhou Liu
QZQiong Zhang
Qiong Zhang
HHHaixia He
Haixia He
Hearing loss (HL) is the most common disorder in newborns with a highly heterogeneous genetic background. Despite significant progress in screening and identifying genes related with congential hearing loss, there are still candidate genes implicated in HL that remain undiscovered. We investigated HL in 43 China families that segregate bilateral sensorineural via whole-exome sequencing(WES) and Sanger sequencing. Variants were found in 10 known non-syndromic hearing loss (NSHL) genes, 5 known syndromic hearing loss(SHL) genes and a candidate HL genes ATP7B. RNA sequencing reveals ATP7B mRNA expression of in developing and adult cochlea. Immunohistochemistry of the adult mouse cochlear tissue revealed prominent expression of ATP7B in the organ of Corti and the spiral ganglion neuron. Overall, we propose a new candidate genes ATP7B for congential hearing loss and novel variants in known HL genes, which expand our understanding of the etiology of HL.

Verified
Journal Article
Open access
PDF file
YJYuan Jin
Yuan Jin
XSXinyu Shi
Xinyu Shi
QZQiong Zhang
Qiong Zhang
BGBei Guo
Bei Guo
YXYing Xiong
Ying Xiong
WCWei Chen
Wei Chen
Tinnitus arises from maladaptive plasticity and abnormal synaptic function, not only in auditory pathways but also in limbic regions. Among these, the cingulate gyrus plays a pivotal part in shaping the emotional burden and sensory filtering disturbances often seen in tinnitus patients. Yet, the specific molecular players operating within this region remain poorly understood, and most existing bioinformatic predictions have not been tested in living systems. Here, we combined multi-database mining with in vivo transcriptomic profiling to identify and validate key proteins and pathways linked to tinnitus in the cingulate gyrus. We built and compared protein–protein interaction networks representing auditory perception, acoustic challenge, and tinnitus states, thereby pinning down candidate hub molecules. To verify these candidates, we used a noise-induced mouse model of tinnitus, confirmed the phenotype via gap prepulse inhibition of acoustic startle (GPIAS), and then performed RNA-seq and qPCR on cingulate gyrus tissue. The bioinformatic screens pointed to AKT1 and TNF as central hubs, suggestive of an inflammatory–survival signaling axis. In our animal experiments, RNA-seq showed a clear rise in Akt1 transcript levels in the tinnitus group, and functional enrichment analysis pointed to marked changes in extracellular matrix organization, cell adhesion, and cytokine receptor pathways. qPCR further corroborated the Akt1 upregulation. Taken together, our integrative strategy establishes AKT1 and TNF as topologically central hub proteins in the cingulate gyrus tinnitus network, and validates Akt1 upregulation in vivo, offering potential biomarker candidates and therapeutic leads for future studies.